Lab study probes c-section blood pressure drugs for safer choices
NCT ID NCT04053478
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study takes tissue samples from women having planned C-sections and tests four drugs (ephedrine, phenylephrine, norepinephrine, vasopressin) in a dish to see how they affect womb muscle and umbilical blood vessels. The goal is to understand which drugs might be safer for mother and baby. It involves 144 participants but is purely a lab experiment, not a treatment trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ephedrine, phenylephrine, norepinephrine, vasopressin
What this could lead to
If successful, this could help doctors choose safer blood-pressure drugs for mothers during C-sections, potentially reducing harm to the baby.
What could go wrong
This is a lab study using tissue samples, not a human trial. Results may not directly apply to real patients, and the drugs' effects in the body could differ.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mount Sinai Hospital
RECRUITINGToronto, Ontario, M5G1X5, Canada
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••